Helix BioPharma Corp. (HBP.TO)
Company Info
Highlights
CA$49.31M
-CA$1.05
-CA$6.00K
-CA$7.13M
CA$0.50 - CA$1.35
CA$2.50
0.18
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of CA$10,000 in Helix BioPharma Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Helix BioPharma Corp. had a return of 4.49% year-to-date (YTD) and 3.33% in the last 12 months. Over the past 10 years, Helix BioPharma Corp. had an annualized return of -18.92%, while the S&P 500 had an annualized return of 11.26%, indicating that Helix BioPharma Corp. did not perform as well as the benchmark.
HBP.TO
4.49%
-0.00%
-15.45%
3.33%
-32.88%
-18.92%
^GSPC (Benchmark)
4.01%
1.13%
9.82%
22.80%
12.93%
11.26%
Monthly Returns
The table below presents the monthly returns of HBP.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.37% | 4.49% | |||||||||||
| 2024 | -9.52% | 0.00% | -5.26% | 22.22% | -4.55% | 14.29% | -4.17% | 9.57% | -5.56% | -31.09% | 6.10% | 2.30% | -15.24% |
| 2023 | 0.00% | -13.64% | 15.79% | -4.55% | 0.00% | 0.00% | 0.00% | 14.29% | -8.33% | -0.00% | 4.55% | -8.70% | -4.55% |
| 2022 | -13.33% | -3.85% | -8.00% | -17.39% | 0.00% | 31.58% | -24.00% | -0.00% | 31.58% | -12.00% | -4.55% | 4.76% | -26.67% |
| 2021 | 94.00% | -20.62% | 10.39% | -0.00% | 12.94% | -14.58% | 1.22% | -3.61% | -28.75% | -10.53% | -9.80% | -34.78% | -40.00% |
| 2020 | -6.72% | 22.40% | 3.27% | 1.27% | -39.37% | -17.53% | -32.50% | -7.41% | -22.00% | -17.95% | 0.00% | 56.25% | -62.69% |
| 2019 | 18.87% | -17.46% | -9.62% | 10.64% | -28.85% | -27.03% | 107.41% | 42.86% | 51.25% | -2.48% | -5.08% | 19.64% | 152.83% |
| 2018 | -12.77% | 9.76% | -0.00% | -11.11% | -6.25% | 20.00% | -22.22% | 1.43% | 5.63% | -33.33% | -6.00% | 12.77% | -43.62% |
| 2017 | -3.25% | -10.74% | -18.80% | -21.30% | 17.65% | -5.00% | -5.26% | 0.00% | 0.00% | -6.67% | -0.00% | 11.90% | -38.96% |
| 2016 | -7.50% | 2.16% | -2.12% | 8.11% | -0.00% | -0.00% | -0.00% | -6.50% | -11.23% | -9.64% | 3.33% | -0.65% | -23.00% |
| 2015 | -16.67% | -8.67% | 38.69% | 3.68% | 1.52% | 0.00% | 0.50% | 5.97% | -5.16% | 5.94% | -3.74% | -2.91% | 11.11% |
| 2014 | 4.17% | -0.00% | 0.00% | 28.67% | -8.29% | 13.56% | -3.48% | 0.52% | -10.26% | -5.71% | 9.09% | -0.00% | 25.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HBP.TO is 53, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Helix BioPharma Corp. (HBP.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Helix BioPharma Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Helix BioPharma Corp. was 100.00%, occurring on Jul 4, 2004. The portfolio has not yet recovered.
The current Helix BioPharma Corp. drawdown is 97.68%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Oct 11, 2000 | 974 | Jul 4, 2004 | — | — | — |
| -96.55% | Oct 22, 1996 | 475 | Aug 17, 1998 | 239 | Jul 16, 1999 | 714 |
| -37.5% | Jun 6, 1996 | 25 | Jul 16, 1996 | 16 | Aug 13, 1996 | 41 |
| -35.29% | Aug 23, 1996 | 38 | Oct 15, 1996 | 4 | Oct 21, 1996 | 42 |
| -30% | Mar 9, 2000 | 48 | May 15, 2000 | 88 | Sep 14, 2000 | 136 |
Volatility
Volatility Chart
The current Helix BioPharma Corp. volatility is 26.95%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Helix BioPharma Corp..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |